LL99-3
CR_1420_Other treatment
Active
Basic Properties
- OID
- 1.3.6.1.4.1.12009.10.1.3420
- Name
- CR_1420_Other treatment
- Description
- NAACCR - RX Summ--Other Treatment-1st Course
- LOINCs using this list
- 1
Answer List
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| No other cancer-directed therapy except as coded elsewhere | 0 | LA4558-8 | |
| Other cancer-directed therapy | 1 | LA4730-3 | |
| Other experimental cancer-directed therapy (not included els | 2 | LA4726-1 | |
| Double-blind study, code not yet broken | 3 | LA3962-3 | |
| Unproven therapy (including laetrile, krebiozen, etc.) | 6 | LA4451-6 | |
| Patient or patient's guardian refused therapy which would ha | 7 | LA4639-6 | |
| Other cancer-directed therapy recommended, unknown if admini | 8 | LA4729-5 | |
| Unknown if other cancer-directed therapy administered | 9 | LA4411-0 |
LOINC terms using this Answer List
| 21949-3 | Other treatment Cancer |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LL99-3 - ValueSet definition
- https:
//fhir.loinc.org/ValueSet/?url=http: //loinc.org/vs/LL99-3 - ValueSet expansion
- https:
//fhir.loinc.org/ValueSet/$expand?url=http: //loinc.org/vs/LL99-3
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright